Motivation: The diversity of biological omics data provides richness of information, but also presents an analytic challenge. While there has been much methodological and theoretical development on the statistical handling of large volumes of biological data, far less attention has been devoted to characterizing their veracity and variability. Results: We propose a method of statistically quantifying heterogeneity among multiple groups of datasets, derived from different omics modalities over various experimental and/or disease conditions. It draws upon strategies from analysis of variance and principal component analysis in order to reduce dimensionality of the variability across multiple data groups. The resulting hypothesisbased inference procedure is demonstrated with synthetic and real data from a cell line study of growth factor responsiveness based on a factorial experimental design. Availability and implementation: Source code and datasets are freely available at https://github. com/yangzi4/gPCA.
Introduction
Biological data obtained from high-throughput omics technologies provide a wealth of information to biomedical researchers, but also poses analytical challenges in terms of both volume and veracity, as biological expression is not only typically high-dimensional, but also highly heterogeneous (Marx, 2013) . While there exist techniques for operating under settings of many variables versus observations (Amini and Wainwright, 2009; Carvalho et al., 2008; Guo et al., 2010; Shao et al., 2011) , this does not address the fact that biological systems are complex in nature and that their observed patterns are both varying across sample groups and diverse across variable types. In this work, we develop a method for quantifying and testing the degree of heterogeneity among multiple sets of data in terms of their dimensionality-reduced factors.
Dimensionality reduction is commonly used as a first step in navigating the complex landscape of biological expression data (Dai et al., 2006; Das et al., 2006; Teodoro et al., 2003; Yeung and Ruzzo, 2001) . Its central goal is to reduce data patterns into relatively few basic components or dimensions of highest importance. The definition of this 'importance' will vary depending on the structure of the data and problem, ranging from the accuracy in reconstructing the data from non-negative (Lee and Seung, 2001) or orthogonal (Wold et al., 1987) parts, to the ability to preserve local neighborhoods (Roweis and Saul, 2000) or pairwise distances (Kruskal, 1964) in low-dimensional manifolds. We will be regarding importance in terms of the variation explained in each component, and will develop insights on the association between multiple data groups from the level of these variation-maximizing reduced factors.
Reducing dimensionality across multiple data groups presents the unique opportunity of comparison across their reduced components. Since these components represent the key elements amongst the datasets, they can provide a more efficient way of describing their patterns, such as in terms of the similarity or diversity amongst groups of samples/features. This has broad applicability in any study involving grouped or stratified data such as subtypes of diseases, subpopulations or experimental conditions. Just as traditional dimensionality reduction reduces the view of single datasets, the integrative framework we present simplifies the comparison of multiple datasets.
Our proposed technique is based on hybridizing the classical principal component analysis (PCA) and analysis of variance (ANOVA) in a way which can be viewed as a multivariate extension of PCA. Currently, many approaches exist for adapting dimensionality reduction to multiple groups. Multi-block partial least squares (Li et al., 2012) apply weighted averaging on predictor variable scores to identify multi-dimensional regulatory modules most highly associated with the response. Multiple canonical correlation analysis (Witten and Tibshirani, 2009 ) combines simultaneous covariance calculations between all dataset pairs to extract highly correlated linear combinations of variables across groups. Integrative non-negative matrix factorization (Yang and Michailidis, 2015) distinguishes between and relates the strengths of common and distinct effects to distill homogeneous modules from heterogeneous noise. Integrative and regularized PCA applies the elastic net penalty (Zou and Hastie, 2005) to mediate principal loadings across multiple data sources (Liu et al., 2016) . In each case the defining objective of the original reduction technique (maximizing covariance, maximizing correlation, minimizing residual error, etc.) is preserved while some modification (e.g. a penalty or constraint) offsets the additional model flexibility. We apply the same construction strategy to develop our framework.
In Section 2.1 we provide pre-requisite background on PCA, before applying its principles to an ANOVA-like formulation in Section 2.2. By viewing PCA from the perspective of residual minimization and relating variation between and within data groups, we produce new statistics for the commonality and fused complexity among multiple data groups. In Section 2.3, we describe using these statistics for hypothesis-based inference on the extent of this commonality. In Section 3, we show how this inference provides unique insights for an existing breast cancer cell line study with factorial design.
Materials and methods

PCA
PCA is a dimensionality reduction technique widely used in many application domains, including bioinformatics (Price et al., 2006; Zheng et al., 2012) . The method identifies key components related to capturing maximum variance that summarize the patterns in the data. Formally, given a column-centered matrix X NÂp comprising of N samples and P features/variables, the goal is to find an orthogonal linear transformation of X in lower dimensions D ( minðN; PÞ that retains maximal variance (Hastie et al., 2009) :
where jj Á jj F denotes the Frobenius norm.
The loading matrixŴ PÂD defines the mapping which projects the data matrix X to the lower dimensional space, whereas the score matrix ðXŴ Þ NÂD is the dimensionality-reduced mapped data matrix whose variance is maximized. The model can be interpreted as reducing the observed patterns of the data into a set of observational latent factors (scores, i.e. rows of XŴ ) and key variable signatures (loadings, i.e. columns ofŴ ). The solution is typically found through a singular value decomposition:
where the top D right singular vectors (in V) are taken as the loadingsŴ . This guarantees that the solutions are nested, i.e.
incrementing the dimension D leads to larger sets of loadings and scores which include the previous loadings and scores. The product of the scores and loadings is a low-rank approximation of the data consisting of D rank-1 layers (d ¼ 1; . . . ; D), which are referred to as principal components:
We will be considering an alternative, but equivalent formulation of PCA (Guo et al., 2010; Zou et al., 2006) , which involves minimizing the sum-of-squares of the residuals of this approximation:Ŵ ¼ arg min
In general, the minimizerŴ is only unique up to unitary transformations, but the approximation XŴŴ T is unique since the subspace spanned by the columns ofŴ is unique.
An ANOVA-like decomposition for PCA
Classical one-way ANOVA (Cox, 2006) decomposes the variation of K sets comprising of N k sample values each (y kn 2 R; n ¼ 1; . . . ; N k ; k ¼ 1; . . . ; K) into the variation within and between groups:
where y kn represents each sample value and y k ; y denote the group and overall means, respectively. Note that the center in each sum-ofsquares term is a sample mean of some form. Our approach involves constructing a similar decomposition for multivariate data in which the centers for the sum-of-squares terms are derived from PCA decompositions.
Suppose that we wish to examine the biological expression profiles of cells across K experimental groups (or disease subtypes, subpopulations, etc.) comprising N ¼ N 1 þ Á Á Á þ N K observations and P variables, represented as X k 2 R N k ÂP ; k ¼ 1; . . . ; K. Following centering and normalization (X k =jjX k jj 2 F ) of the columns, we may consider performing PCA on the full data X f ¼ ðX k Þ K k¼1 2 R NÂp jointly and on each individual dataset X k separately:
At the uniquely defined optima, the PCA approximation X fŴ fŴ T f is the rank-D center of the sum-of-squares term associated with X f , and each PCA approximation X kŴ kŴ T k is the rank-D center of the sum-of-squares term associated with X k . One may notice that these sum-of-squares terms:
can play an analogous role to the total and within-group sum-ofsquares of ANOVA.
For the between-group sum-of-squares, the classical ANOVA approach is to compute the sum-of-squares of the group means Y k with the center as the overall mean Y , which can be computed from taking the mean of the group means. Similarly, we can compute the sum-of-squares of the separate PCA approximations X kŴ kŴ T k with the center obtained from applying PCA to these PCA approximations. This is done by combining the separate approximations as a single matrixX s ¼ ðX kŴ kŴ
NÂp and reapplying
At the unique optimum, the PCA approximationX sŴ sŴ T s is the rank-D center of the sum-of-squares term associated with X s :
Combing the terms in (1) and (2), we have the PCA analog to the ANOVA decomposition of sum-of-squares:
A schematic is given in Figure 1 , which summarizes the entire procedure in terms of PCA approximations. The decomposition in Equation (3) can be viewed as the (approximate) equivalence of two paths for arriving at a rank-D approximation of the complete data. One path is to perform a rank-D PCA on the joint data X f . The other is to perform a rank-D PCA separately on each X k and reapply a rank-D PCA on the combined approximations X s . For synthetic random data matrices, Equation (3) generally only holds approximately, because the data columns are centered differently depending on whether PCA is applied jointly or separately. Consequently, W f ;Ŵ s are in general not identical.
Using this ANOVA-based framework, we can arrive at estimates for the commonality (â), noise level (r) and fused complexity (D) associated with the collective data groups: Non-parametric bootstrapping can be performed to improve stability via replicating datasets from sampling rows with replacement within each data group, and averaging over the resultingr's.
The full derivation of this procedure is provided in Supplementary Sections S2 and S3, and applies properties of principal angles. As evident from this derivation, a 2 ð0; 1Þ represents the proportion of common signal among the data groups given that they are comprised of mixtures of common and distinct components, and r > 0 represents the noise-to-signal level associated within each dataset. The fused rank D is the rank used for all of the PCA approximations in the decomposition, and represents the complexity of what would be a common structure had we fitted a groupwise PCA (gPCA) framework over the datasets. Notably, datasets with similar underlying factors will tend to yield a smaller fused rank, while those with different underlying factors will require a larger fused rank to describe via gPCA.
It is important to distinguish the fused rank as presented here with the joint rank of the true common component as considered in joint individual variance explained (JIVE, Lock et al., 2013) . JIVE is another PCA-based decomposition for multiple datasets (discussed further in Supplementary Section S5), which describes datasets in terms of joint and individual structures with the restriction of orthogonal rows. While structurally similar to gPCA, JIVE imposes fewer restrictions on the common component such that its joint rank has a different interpretation. Despite this difference in restriction however, any JIVE decomposition can be represented as a gPCA decomposition in higher dimensions, and the ensuing gPCA homogeneity/heterogeneity tests do not sacrifice functionality. Details are provided in Supplementary Section S5.
Testing for groupwise structure among PCA components
With information on the strength and fused complexity of the signal structures (r;D), we are ready to describe the commonality among these structures withâ. In essence, a addresses a similar question as the ANOVA F-statistic, except we are evaluating differences in principal components instead of differences in means across groups. The second stage of our procedure, referred to here as gPCA, consists of calculating the statistical significance ofâ via two complementary approaches. We let p 1 ðaÞ denote the P-value associated with observingâ at least as large as a assuming complete heterogeneity. We let p 2 ðaÞ denote the P-value associated with observingâ at least as small as a assuming complete homogeneity.
For p 1 ðaÞ ¼ Pðâ ! aÞ, we apply linear algebra (details in Supplementary Section S4) to obtain a probability distribution forâ. The probability of observingâ at least as large as a is:
; a 2 0; 1 ð Þ 
The null hypothesis associated with this P-value is that the underlying patterns of the data are heterogeneous over the K groups (i.e. the generating subspaces are different). Specifically we assume that the originating subspaces are independently and uniformly generated on the Grassmann manifold of D-planes in R p (with
2 ), which is the space of all D-dimensional linear subspaces of R p (Absil et al., 2006) .
Note that this is not the same as assuming a ¼ 0 (i.e. that these subspaces are orthogonal).
For p 2 ðaÞ ¼ Pðâ aÞ, we assume the null hypothesis that the underlying patterns of the data are homogeneous over the K groups (i.e. the generating subspaces are the same).
To simulate a homogeneous distribution, we can generate replicate datasets by sampling rows with replacement (bootstrapping) from only one of the K data groups at a time. In our applications, 1000 replicates were generated using each data group for a total of 1000 Ã K. We can apply gPCA to each of these replicates, and the empirical distribution ofâ can be used to compute our P-value as the proportion of simulatedâ at least as small as a:
3 Results
Simulation study
We provide here numerical results for the estimation of D and a, as well as the P-values associated with the latter. Data were generated under the model described in Supplementary Section S2. In short, we assume datasets X k 2 R N k Âp (letting N ¼ P k N k ) to be generated under a basic factor model:
with true loadings W k composed of mixtures of common (W c ) and distinct (W d;k ) parts:
The data lie primarily on the D-dimensional subspaces W k generated from W k . The parameters a 2 ð0; 1Þ and r > 0 denote the levels of commonality between groups and noise within groups, respectively.
We first evaluate the accuracy rate of selecting the true fused rank D, and compared with conventional PCA rank selection methods. These include the Laplace method (Minka, 2000) and the Bayesian information criterion (Kass and Raftery, 1995) , which maximize evidence under a Bayesian framework. The KaiserGuttman method is the classical approach of using the average of eigenvalues as a stopping threshold (Jackson, 1993) . Kritchman and Nadler (2008) apply principles from random matrix theory to a sequential hypothesis testing procedure. All of these methods were implemented in Python, with support from the scikit-learn package (Pedregosa et al., 2011) . The joint rank estimate of JIVE was also considered using its Matlab implementation (Lock et al., 2013) . Results were averaged over D with 25 repetitions each for a total of 100 for each scenario. Table 1 shows the rates of correctly identifying the fused rank D using gPCA, JIVE and conventional PCA rank selectors. We see that gPCA most accurately selects the true fused rank, as it detects the common and distinct components of the data under the appropriate framework. Table 2 displays the distributions ofâ; p 1 ; p 2 across levels of commonality. Estimateâ appears accurate except when the true a is small, i.e. when the signal of the common component is less distinguishable from noise. Importantly, the significance regions for the P-values p 1 and p 2 agree with their roles in testing for homogeneity/ heterogeneity among datasets. As the true a approaches above and below a threshold, p 1 and p 2 , respectively, shrink toward zero. In Supplementary Section S6, we show that these hypothesis tests are robust to slight misspecifications of D max .
3.2 Application to studying growth factor responsiveness across breast cancer subtypes 3.2.1 Background and data processing Breast cancer is a very diverse disease in terms of its clinical attributes (Anderson and Matsuno, 2006 ) and molecular signature (The Cancer Genome Atlas Network, 2012). Clinically, there are primarily four subtypes determined based on the presence of immunohistochemical markers estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) in the tissue (Parise et al., 2009 ), which are associated with different rates of survival (Onitilo et al., 2009 ) and treatment strategies (Weigel and Dowsett, 2010) . These subtypes have been shown to correlate with molecular subtypes derived from gene expression (Sorlie et al., 2003) and microRNA expression (Blenkiron et al., 2007) profiles. Such molecular heterogeneity presents a significant challenge and opportunity not only for understanding breast cancer at the genomic level but also for developing more refined and personalized therapies that handle clinical heterogeneity.
In the following example, we demonstrate how the gPCA model can be used for groupwise inference in a factorial design study investigating growth factor responsiveness in breast cancer cell lines. The target study (Niepel et al., 2014) accounts for a variety of experimental conditions across different breast cancer subtypes, ligand (growth factor) types, concentrations of ligand, exposures times and signaling pathways. Using gPCA, we derive estimates for the fused rank and commonality (along with significance calculations) to provide an ANOVA-based decomposition of variation along the levels of each of these factors.
We obtained pre-and post-treatment phosphorylation levels of ERK and AKT kinases to quantify activity in their respective growth-related MAPK and PI3K/AKT pathways. The fold-change (post-to pre-treatment ratio) was assessed for these two kinases following exposure to 15 different growth factors at two doses (1 and 100 ng/ml) and three time points (10, 30 and 90 min). Measurements were repeated across a total of 39 breast cancer cell lines spanning three clinical subtypes: 18 triple negative (TN, ER-/PR-/HER2-), 11 HER2-overexpressing (H2, HER2þ) and 10 hormone receptor positive (HR, ERþ or PRþ). The data can be obtained from http://lincs.hms.harvard.edu/niepelbmcbiol-2014.
Multivariate comparisons across experimental factors
We first chose to study how the distribution of ligand responsiveness compares across ligand concentration, kinase type, time of measurement and disease subtype. For each of these experimental factors, gPCA was performed globally (among all factor levels) and pairwise (between each pair of factor levels) for every combination of the remaining factors except for disease subtype. Supplementary Tables S5-S8 in Supplementary Section S7 summarize our findings, which include estimates of fused rank and commonality, the associated P-values, and the proportion of attributed within-group variation (WSS ¼ WSS=ðWSS þ BSSÞ). Bonferroni correction was applied given the number of effective independent tests m (i.e. significance level set to 0:05=m).
Across ligand concentration, kinase type and time of measurement (Supplementary Tables S5-S7 in Supplementary Section S7), growth factor responsiveness appears generally homogeneous in distribution (significant p 1 ). In other words, these conditions seem to have little effect on the observed patterns of induced kinase activity among the cell line and ligand combinations. This suggests that little change in findings would result from adjusting these conditions.
In contrast to these findings, Niepel et al. (2014) report significant differences in ligand responsiveness across these experimental factors. Notably, these differences were largely observed from comparisons on individual ligands/cell lines, whereas our analyses were conducted across multiple ligands/cell lines. The finding of localized heterogeneity despite global homogeneity is analogous to observing from ANOVA significant pairwise differences despite absence of significant global differences. Restricting to a subset of data can help to detect weak signals but at the risk of finding false positives, particularly when the global comparison is non-significant. Therefore, gPCA provides value in this setting by suggesting more global comparisons where appropriate, namely when there is sufficient confidence in the homogeneity of the underlying patterns.
When gPCA was applied across disease subtype (Supplementary  Table S8 in Supplementary Section S8), we observed some heterogeneity in growth factor responsiveness, largely restricted to pAKT levels. To investigate whether a subgroup of ligand types was largely responsible for this, we separated the ligands into ErbBassociated (EGF, EPR, BTC, HRG) and non-ErbB-associated (VEGF165, INS, IGF-1/2, PDGF-BB, HGF, SCF, FGF-1/2, NGFbeta, EFNA1) groups. Figures 2 and 3 show heatmaps of pAKT and pERK responsiveness to ligands in all cell lines, measured 30 min after treatment of 100 and 1 ng/ml of ligand respectively. The heterogeneity and homogeneity of patterns across subtypes is evident.
With gPCA, we have reduced across the vast range of combinations of experimental conditions to identify the key source of heterogeneity as the relationship between disease subtype and ligand type. From here, more targeted analyses may proceed. In the original analysis, Niepel et al. (2014) report that cells of the TN subtype were the most responsive, while H2 and HR were particularly sensitive to certain classes of growth factors (ErbB2-related and FGF1/FGF2/HRG, respectively). These findings are reflected in the heatmaps and can be supported statistically with univariate comparisons (F-test or t-test). For instance, for the H2 subtype under the conditions described in Figure 2 , the mean ErbB ligand response was significantly different Fig. 3 . Heatmap of log10-fold change of pERK measured 30 min in response to 1 ng/ml treatment of ligand, among all ligand types and all cell lines. Breast cancer subtype and ligand subgroup memberships are indicated. Growth factor sensitivity of ERK is homogeneous in distribution but different in level across subtypes Fig. 2 . Heatmap of log10-fold change of pAKT measured 30 min in response to 100 ng/ml treatment of ligand, among all ligand types and all cell lines. Breast cancer subtype and ligand subgroup memberships are indicated. Growth factor sensitivity of AKT is heterogeneous in distribution but similar in level across subtypes (t ¼ 10.4, P-value ¼ 1:3e À19 ) from that of non-ErbB ligands. For the HR subtype under the conditions described in Figure 3 , the mean response of FGF1, FGF2 and HRG was significantly different (t ¼ 4.28, P-value ¼ 3:3e À5 ) than that of other ligands.
Under these same two experimental conditions, we partitioned the data into ErbB and non-ErbB ligand subgroups, and reapplied gPCA to compare ligand responsiveness across disease subtypes (Tables 3 and 4) . Ligand response patterns for AKT were diverse across subtypes, especially between TN and HR subtypes. NonErbB-induced responses of ERK were more homogeneous across subtypes than ErbB-induced responses. We can compare these results with those of F-test comparisons from ANOVA (Tables 5  and 6 ). Mean ErbB-induced activity for AKT was similar across subtypes, as was mean non-ErbB-induced activity to a lesser extent. In contrast, we see dramatic differences in mean ligand-induced ERK response across almost all subtypes for both ligand subgroups. In summary, we see that growth factor sensitivity of AKT is heterogeneous in distribution but similar in level across subtypes and that growth factor sensitivity of ERK is homogeneous in distribution but different in level across subtypes. These findings suggest that across TN, H2, and HR breast cancer subtypes, AKT activation follows different signal transduction pathways, while ERK activation follows similar pathways at different sensitivities.
Discussion
The availability of biological data is expanding in terms of not only volume but also variety. This has led to growing interest in developing new analytic methods which are able to draw upon multiple data sources and consolidate the information within. In this paper we have approached this challenge from the perspective of dimensionality reduction, a widely used tool for reducing complex biological patterns to fundamental components. At the level of these core components, we construct an integrative framework that provides novel insight into the variational patterns within and between multiple data groups.
Our approach combines the variation decomposition structure of ANOVA with the variation reduction procedure of PCA. We expand the study of within and between variation to the multivariate setting, which deals with comparisons of subspaces of the group signatures via principal angles. This key element provides a novel estimation scheme for the complexity and commonality that characterizes multiple groups of data. Applying properties of principal angles in turn allows for theoretical significance calculations in addition to the conventional permutation-based calculations.
In our data application, we have demonstrated the utility of this multivariate comparison framework to a factorial design study of Note: Data dimensions: ð18 þ 11 þ 10 celllines Â 4 or 11 ligandsÞ. Significance (denoted by shading) was assessed at level 0:05=m for m¼8 independent tests in each scenario). Note: Data dimensions: ð18 þ 11 þ 10 celllines Â 4 or 11 ligandsÞ. Significance (denoted by shading) was assessed at level 0.05 for m¼8 independent tests in each scenario). Note: Data dimensions: ð18 þ 11 þ 10 celllines Â 4 or 11 ligandsÞ. Significance (denoted by shading) was assessed at level 0:05=m for m¼8 independent tests in each scenario). Note: Data dimensions: ð18 þ 11 þ 10 celllines Â 4 or 11 ligandsÞ. Significance (denoted by shading) was assessed at level 0:05=m for m ¼ 8 independent tests in each scenario). growth factor response signatures. Not surprisingly, the method provides an ANOVA-type layout of conclusions composed of global assessments (of homogeneity or heterogeneity) across all data groups followed by pairwise assessments between groups. Owing to the ability of PCA-type decompositions to reduce multivariate patterns, we have a way of performing such assessments over matrices of data values rather than vectors. This allows a novel analytic approach for studying data organized into groups on a broader scale.
Despite originating from fairly classical statistical methods, the style of inference provided by gPCA represents a novel approach to multivariate and multi-group analysis. There is of course room for refinement, such as in the assumptions used in deriving the estimates for commonality and fused rank. Moreover random matrix theory may play a key role in understanding the relationship between the generating principal components, the principal angles formed between their subspaces and the overall groupwise decomposition of variation.
